Clinical Trial Update: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a therapy for hyperphosphatemia in patients with chronic kidney disease on peritoneal dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Renal Dialysis | Phase 3 | Status: COMPLETED